The effect of antihypertensive therapy on responsiveness to local intra-arterial NG-monomethyl-L-arginine in patients with essential hypertension

Journal of Hypertension

Volumn 12, Issue 9, 1994, Pages 1047-1052

  Lyons, Declan ^a   Webster, John ^a   Benjamin, Nigel ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Endothelium; Hypertension; Nitric oxide; Plethysmography

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; ENALAPRIL; N(G) METHYLARGININE; NITRIC OXIDE;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BRACHIAL ARTERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ESSENTIAL HYPERTENSION; FEMALE; FOREARM BLOOD FLOW; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VASCULAR ENDOTHELIUM; VEIN OCCLUSION PLETHYSMOGRAPHY;

EID: 0028122537     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/00004872-199409000-00009     Document Type: Article

References (24)

1. Palmer RMJ, Ferrige AC, Moneada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987, 327:524–526.
2. Yang Z, von Segesser L, Bauer E, Stultz P, Turina M, Lüscher TF: Different activation of the endothelial L-arginine and cyclooxygenase pathway in the human internal mammary artery and saphenous vein. Circ Res 1991, 68:52–60.
3. Moncada S, Radomski MW, Palmer RMJ: Endothelium derived relaxing factor: identification as nitric oxide and role in the control of vascular tone and platelet function. Biochem Pharmacol 1988, 37:2495–2501.
4. Palmer RMJ, Ashton DS, Moneada S: Vascular endothelial cells synthesise nitric oxide from L-arginine. Nature 1988, 33:664–666.
5. Vallance P, Collier J, Moneada S: Effects of endothelium derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989, ii:997–1000.
6. Furchgott RF, Zawadski JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980, 288:373–376.
7. Gabbiani G, Glemes G, Guelpa C, Valoton MB, Badonnel MC, Huttner I: Morphological and functional changes of the aortic intima during experimental hypertension. Am J Pathol 1979, 96:399–422.
8. G-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal. J Hypertens 1992, 10:1025–1031.
9. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA: Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation 1993, 87:1468–1474.
10. Palmer RMJ, Rees DD, Ashton DS, Moneada S: L-arginine is the physiological precursor for the formation of nitric oxide in endothelium dependent relaxation. Biochem Biophys Res Commun 1988, 153:1251–1256.
11. Baylis C, Mitruka B, Deng A: Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest 1992, 90:278–281.
12. Haynes WG, Noon JP, Walker BR, Webb DJ: Inhibition of nitric oxide synthesis increases blood pressure in healthy humans. J Hypertens 1993, 11:1375–1380.
13. Jamieson MJ, Webster J, Witte K, Huggins M, MacDonald TM, de Beaux A, et al: An evaluation of the A&D UA-751 sphyg-momanometer. J Hypertens 1990, 8:607–619.
14. Whitney RJ: The measurement of volume changes in human limbs. J Physiol 1953, 121:1–27.
15. Greenfield ADM, Patterson GC: Reactions of the blood vessels of the human forearm to increases in transmural pressure. J Physiol 1954, 125:508–524.
16. Vanhoutte PM: The endothelium: modulator of vascular smooth-muscle tone. N Engl J Med 1988, 319:512–513.
17. Vane JR, Änggård EE, Botting RM: Regulatory functions of the vascular endothelium. N Engl J Med 1990, 323:27–36.
18. Whittle BJR, Lopez-Belmonte J, Rees DD: Modulation of the vasodepressor actions of acetylcholine, bradykinin, substance P and endothelin in the rat by a specific inhibitor of nitric oxide formation. Br J Pharmacol 1989, 98:646–652.
19. Panza JA, Quyyumi AA, Callahan TS, Epstein SE: Effect of antihypertensive treatment on endothelium-dependent vascular relaxation in patients with essential hypertension. J Am Coll Cardiol 1993, 21:1145–1151.
20. Cockroft JR, Chowienczyk PJ, Benjamin N, Ritter JM: Preserved endothelium dependent vasodilatation in patients with essential hypertension. N Engl J Med 1994, 330:1036–1040.
21. G-monomethyl-L-arginine of vasodilator effects of acetyl-choline and methacholine in human forearm vasculature. Br J Pharmacol 1993, 110:736–738.
22. Greene LJ, Camargo ACM, Krieger EM, Stewart JM, Ferreira SH: Inhibition of the conversion of angiotensin I to II and potentiation of bradykinin by small peptides present in bothrops jararaca venom. Circ Res 1972, 31 (suppl II):II62–II71.
23. G-monomethyl-L-arginine on forearm blood flow in treated hypertensive patients [abstract]. Proc Br Pharmacol Soc Sept 1992, C106.
24. Swartz SL, Williams GH, Hollenberg NK, Moore TJ, Dluhy RG: Converting enzyme inhibition in essential hypertension: the hypotensive response does not reflect only reduced angiotensin II formation. Hypertension 1979, 1:106–111.